A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet

被引:9
作者
Miyaoka, Yuta [1 ]
Jin, Denan [2 ]
Tashiro, Keitaro [1 ]
Masubuchi, Shinsuke [1 ]
Ozeki, Maiko [1 ]
Hirokawa, Fumitoshi [1 ]
Hayashi, Michihiro [1 ]
Takai, Shinji [2 ]
Uchiyama, Kazuhisa [1 ]
机构
[1] Osaka Med Coll, Dept Gen & Gastroenterol Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
[2] Osaka Med Coll, Grad Sch Med, Dept Innovat Med, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan
基金
日本学术振兴会;
关键词
chymase; fibrosis; hamster; nonalcoholic steatohepatitis; steatosis; CHYMASE INHIBITOR PREVENTS; CHOLINE-DEFICIENT DIET; LIVER-DISEASE; MAST-CELLS; RAT MODEL; FIBROSIS; PROGRESSION; ACTIVATION; SURVIVAL; THERAPY;
D O I
10.1538/expanim.17-0126
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Nonalcoholic steatohepatitis (NASH), in which there is steatosis and fibrosis in the liver, is linked to metabolic syndrome and progresses to hepatic cirrhosis. In this study, a novel hamster NASH model derived from metabolic syndrome was made using hamsters. Hamsters were fed a normal or a high-fat and high-cholesterol (HFC) diet for 12 weeks. Body weight and the ratio of liver weight to body weight were significantly greater in HFC diet-fed hamsters than in normal diet-fed hamsters. Triglyceride, low-density lipoprotein cholesterol, and glucose levels in blood were significantly increased in HFC diet-fed hamsters, and blood pressure also tended to be high, suggesting that the HFC diet-fed hamsters developed metabolic syndrome. Hepatic steatosis and fibrosis were observed in liver sections of HFC diet-fed hamsters, as in patients with NASH, but they were not seen in normal diet-fed hamsters. Chymase generates angiotensin II and transforming growth factor (TGF)-beta, both of which are related to hepatic steatosis and fibrosis, and a significant augmentation of chymase activity was observed in livers from HFC diet-fed hamsters. Both angiotensin II and TGF-beta were also significantly increased in livers of HFC diet-fed hamsters. Thus, HFC diet-fed hamsters might develop metabolic syndrome-derived NASH that clinically resembles that in NASH patients.
引用
收藏
页码:239 / 247
页数:9
相关论文
共 22 条
[11]   Chymase inhibitor prevents the development and progression of non-alcoholic steatohepatitis in rats fed a high-fat and high-cholesterol diet [J].
Miyaoka, Yuta ;
Jin, Denan ;
Tashiro, Keitaro ;
Komeda, Koji ;
Masubuchi, Shinsuke ;
Hirokawa, Fumitoshi ;
Hayashi, Michihiro ;
Takai, Shinji ;
Uchiyama, Kazuhisa .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 134 (03) :139-146
[12]   Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis [J].
Ota, Tsuguhito ;
Takamura, Toshinari ;
Kurita, Seiichiro ;
Matsuzawa, Naoto ;
Kita, Yuki ;
Uno, Masafumi ;
Akahori, Hiroshi ;
Misu, Hirofumi ;
Sakurai, Masaru ;
Zen, Yoh ;
Nakanuma, Yasuni ;
Kaneko, Shuichi .
GASTROENTEROLOGY, 2007, 132 (01) :282-293
[13]   Green Tea Extract Suppresses NFκB Activation and Inflammatory Responses in Diet-Induced Obese Rats with Nonalcoholic Steatohepatitis [J].
Park, Hea Jin ;
Lee, Ji-Young ;
Chung, Min-Yu ;
Park, Young-Ki ;
Bower, Allyson M. ;
Koo, Sung I. ;
Giardina, Charles ;
Bruno, Richard S. .
JOURNAL OF NUTRITION, 2012, 142 (01) :57-63
[14]   The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels [J].
Park, Hyohun ;
Hasegawa, Goji ;
Shima, Toshihide ;
Fukui, Michiaki ;
Nakamura, Naoto ;
Yamaguchi, Kanji ;
Mitsuyoshi, Hironori ;
Minami, Masahito ;
Yasui, Kohichiroh ;
Itoh, Yoshito ;
Yoshikawa, Toshikazu ;
Kitawaki, Jo ;
Ohta, Mitsumiro ;
Obayashi, Hiroshi ;
Okanoue, Takeshi .
CLINICA CHIMICA ACTA, 2010, 411 (21-22) :1735-1740
[15]   A novel chymase inhibitor, 4-[1-{[bis-(4-methyl-phenyl)methyl]-carbamoyl}-3-(2-ethoxy-benzyl)-4-oxo-azetidine-2-yloxy]-benzoic acid (BCEAB), suppressed cardiac fibrosis in cardiomyopathic hamsters [J].
Takai, S ;
Jin, D ;
Sakaguchi, M ;
Katayama, S ;
Muramatsu, M ;
Sakaguchi, M ;
Matsumura, E ;
Kim, S ;
Miyazaki, M .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2003, 305 (01) :17-23
[16]   Chymase inhibition improves vascular dysfunction and survival in stroke-prone spontaneously hypertensive rats [J].
Takai, Shinji ;
Jin, Denan ;
Chen, Hong ;
Li, Wen ;
Yamamoto, Hideyuki ;
Yamanishi, Kyosuke ;
Miyazaki, Mizuo ;
Higashino, Hideaki ;
Yamanishi, Hiromichi ;
Okamura, Haruki .
JOURNAL OF HYPERTENSION, 2014, 32 (08) :1637-1649
[17]   Multiple Mechanisms for the Action of Chymase Inhibitors [J].
Takai, Shinji ;
Jin, Denan ;
Miyazaki, Mizuo .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2012, 118 (03) :311-316
[18]   Chymase inhibitor prevents the nonalcoholic steatohepatitis in hamsters fed a methionine- and choline-deficient diet [J].
Tashiro, Keitaro ;
Takai, Shinji ;
Jin, Denan ;
Yamamoto, Hiromi ;
Komeda, Koji ;
Hayashi, Michihiro ;
Tanaka, Kazuhiko ;
Tanigawa, Nobuhiko ;
Miyazaki, Mizuo .
HEPATOLOGY RESEARCH, 2010, 40 (05) :514-523
[19]   Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis [J].
Tilg, Herbert ;
Moschen, Alexander R. .
HEPATOLOGY, 2010, 52 (05) :1836-1846
[20]   Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis [J].
Tiniakos, Dina G. ;
Vos, Miriam B. ;
Brunt, Elizabeth M. .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2010, 5 :145-171